| Date | Company | Compound | Disease | Type of agreement | Therapeutic area | Type of Information |
|---|---|---|---|---|---|---|
| 2015-09-25 | Curevac (Germany) International AIDS Vaccine Initiative (IAVI) | AIDS vaccines | HIV infection | collaboration |
Infectious diseases | Collaboration agreement |
| 2015-09-25 | Aduro Biotech (USA - CA) Incyte (USA - DE) | epacadostat and CRS-207 | ovarian cancer | clinical research |
Cancer - Oncology | Clinical research agreement |
| 2015-09-25 | MedImmune (USA - global biologics arm of AstraZeneca (UK) 3M Drug Delivery Systems (USA - MN) | toll-like receptor (TLR) agonists including MEDI9197 (formerly 3M-052) | solid tumors | R&D collaboration |
Cancer - Oncology | R&D agreement |
| 2015-09-25 | Therametrics (Switzerland) Cloud Pharmaceuticals (USA - NC) | Huntington’s disease, amyotrophic lateral sclerosis (ALS), progressive supranuclear palsy (PSP), frontotemporal dementia (FTD) and other orphan CNS diseases | collaboration |
CNS diseases - Rare diseases | Collaboration agreement | |
| 2015-09-24 | Exelixis (USA - CA) | nomination |
Cancer - Oncology | Nomination | ||
| 2015-09-24 | Pfizer (USA - NY) Merck KGaA (Germany) - Dako (Denmark), an Agilent Technologies company (USA - CA) | companion diagnostic for avelumab (MSB0010718C) | development commercialisation |
Cancer - Oncology | Development agreement | |
| 2015-09-24 | Regeneron Pharmaceuticals (USA - NY) Icahn School of Medicine | R&D |
R&D agreement | |||
| 2015-09-24 | Bind Therapeutics (USA - MA) Pfizer (USA - NY) | Accurin™s utilizing select small molecule targeted therapies | solid tumors | collaboration |
Cancer - Oncology | Exercise of an option agreement |
| 2015-09-24 | PlaqueTec (UK) | nomination |
Cardiovascular diseases - Diagnostic | Nomination | ||
| 2015-09-24 | Novartis (Switzerland) | nomination |
Nomination | |||
| 2015-09-23 | AC Immune (Switzerland) Nestlé Institute of Health Sciences (Switzerland) | Tau diagnostic assay | Alzheimer’s disease | R&D collaboration |
Diagnostic - Neurodegenerative diseases | R&D agreement |
| 2015-09-23 | ImaginAb (USA - CA) | nomination |
Technology - Services - Cancer - Oncology | Nomination | ||
| 2015-09-23 | Illumina (USA - CA) WIN Consortium | collaboration |
Cancer - Oncology | Collaboration agreement | ||
| 2015-09-23 | Promethera Biosciences (Belgium) | nomination |
Genetic diseases - Hepatic diseases - Liver diseases - | Nomination | ||
| 2015-09-23 | Agilent Technologies (USA - CA) Carleton University (Canada) | Carleton Mass Spectrometry Center | opening of new premises |
Technology - Services | Opening of new premises | |
| 2015-09-23 | Abivax (France) | nomination |
Infectious diseases | Nomination | ||
| 2015-09-23 | Argos Therapeutics (USA - NC) | nomination |
Nomination | |||
| 2015-09-23 | NeRRe Therapeutics (UK) | nomination | Nomination | |||
| 2015-09-22 | H3 Biomedicine (USA - MA) Selvita (Poland) | breakthrough precision medicines for cancers | collaboration R&D |
Cancer - Oncology | Collaboration agreement | |
| 2015-09-22 | Novo Nordisk (Denmark) Food and Drug Administration of the Islamic Republic of Iran (Iran) | manufacturing plant for FlexPen® prefilled devices in Iran | diabetes | construction of a production plant |
Metabolic diseases | Construction of a production plant |
